Table 2.
Patient-related clinical data and histological analysis.
| Patient | Gender | Age (years) | Site (ADA) | Layers | STH1 (mm) | Days to biopsy | STH2 (mm) | STH gain (mm) | Additional surgery or biomaterials | Histological results |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | m | 58 | #7 | 1 | 2 | 168 | 3 | 1 | ARP dentin + Memlok RCM (107 d before STA | No residues and mild inflammation |
| 1 | m | 58 | #10 | 1 | 2 | 168 | 3 | 1 | ARP dentin + Memlok RCM (107 d before STA) | No residues and mild inflammation |
| 2 | m | 61 | #22 | 1 | 2 | 96 | 2.5 | 0.5 | None | No residues and mild inflammation |
| 2 | m | 61 | #27 | 1 | 1.5 | 96 | 2.5 | 1 | GBR AB | Residues and mild inflammation |
| 3 | f | 65 | #19 | 1 | 2.5 | 180 | 3 | 0.5 | None | No residues and inflammation-free |
| 3 | f | 65 | #20 | 1 | 2.5 | 268 | 3 | 0.5 | GBR AB | No residues and inflammation-free |
| 4 | f | 33 | #29 | 2 | 2 | 61 | 3 | 1 | None | Possible residues and inflammation-free |
| 4 | f | 33 | #30 | 2 | 2 | 93 | 3 | 1 | GBR AB + MinerOss X | No residues and mild inflammation |
| 5 | f | 77 | #22 | 2 | 2 | 182 | 3.5 | 1.5 | GBR dentin | No residues and mild inflammation |
| 5 | f | 77 | #27 | 2 | 2 | 182 | 3.5 | 1.5 | GBR dentin | No residues and mild inflammation |
| 6 | f | 51 | #29 | 1 | 2.5 | 110 | 3 | 0.5 | GBR AB | Residues, foreign body reaction, and moderate inflammation |
| 7 | f | 66 | #19 | 1 | 2 | 126 | 3 | 1 | GBR AB | Residues, foreign body reaction, and moderate inflammation |
| 8 | m | 75 | #8 | 1 | 2.5 | 100 | 3 | 0.5 | GBR MinerOss X + Memlok RCM | Residues and mild inflammation |
| 9 | f | 62 | #28 | 1 | 2.5 | 151 | 3 | 0.5 | GBR AB + Maxgraft CCG + Memlok RCM | Residues and mild inflammation |
| 10 | m | 64 | #30 | 1 | 2.5 | 142 | 3 | 0.5 | GBR dentin | No residues and minimal inflammation |
| 11 | m | 76 | #21 | 2 | 2 | 66 | 3 | 1 | GBR AB | No residues and mild inflammation |
| 12 | f | 54 | #19 | 1 | 2 | 240 | 3 | 1 | GBR AB | No residues and minimal inflammation |
| 13 | f | 62 | #30 | 1 | 2 | 108 | 2.5 | 0.5 | ARP MinerOss X + Memlok RCM (190 d before STA), GBR with bone from ARP-site | No residues and minimal inflammation |
| 14 | m | 61 | #29 | 2 | 2,5 | 164 | 3.5 | 1 | GBR MinerOss X + Ossix plus | Residues and mild inflammation |
| 15 | m | 55 | #18 | 2 | 2 | 133 | 3.5 | 1.5 | GBR AB | No residues and mild inflammation |
| 16 | f | 65 | #29 | 2 | 2 | 121 | 3 | 1 | GBR AB | No residues and moderate inflammation |
| 17 | f | 31 | #4 | 2 | 2.5 | 162 | 4 | 1.5 | GBR AB | No residues and inflammation-free |
| 18 | m | 56 | #18 | 2 | 2 | 143 | 3.5 | 1.5 | ARP MinerOss X + Jason fleece (292 d before STA), GBR with bone from ARP-site + Memlok RCM | Residues and minimal inflammation |
| 19 | f | 52 | #30 | 2 | 2 | 176 | 3 | 1 | GBR AB + Volumax (138d before STA), GBR with bone from ARP-site | Residues and minimal inflammation |
| 20 | m | 57 | #18 | 1 | 2.5 | 227 | 3 | 0.5 | GBR AB | No residues and minimal inflammation |
| 21 | m | 52 | #19 | 2 | 1.5 | 127 | 2.5 | 1 | None | No residues and minimal inflammation |
| 22 | m | 46 | #8 | 1 | 2.5 | 445 | 3 | 0.5 | GBR MinerOss X + Memlok RCM | No residues and minimal inflammation |